Trying huperzine A put me on the path to being diagnosed with MG
Columnist Shawna Barnes was on the hunt for a clue to her MG symptoms when a late-night search on the internet brought her to huperzine A.| Myasthenia Gravis News
I know none of the symptoms of myasthenia gravis (MG) directly affect how I look. There’s no sudden body change or visible sign that screams “something is wrong.” But anything […] The post More than muscle weakness: My disease affects my self-esteem appeared first on Myasthenia Gravis News.| Myasthenia Gravis News – The Web's Daily Resource for Myasthenia Gravis News
Note: This column describes the author’s own experiences with Ultomiris (ravulizumab-cwvz). Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a therapy. When […] The post The miracles of science, and a hamster that helped me breathe appeared first on Myasthenia Gravis News.| Myasthenia Gravis News – The Web's Daily Resource for Myasthenia Gravis News
People who recover from myasthenia gravis (MG) after long-term treatment have higher numbers of certain subsets of monocytes — a type of immune cell — and lower numbers of others, […] The post Immune cell types may predict recovery in MG, study finds appeared first on Myasthenia Gravis News.| Myasthenia Gravis News – The Web's Daily Resource for Myasthenia Gravis News
Vyvgart (efgartigamod) rapidly eased symptoms of generalized myasthenia gravis (gMG) and prevented complications before, during, and after surgery in a 23-year-old woman, a case study reported. The woman required surgery […] The post Vyvgart eases gMG, prevents surgery complications: Case study appeared first on Myasthenia Gravis News.| Myasthenia Gravis News – The Web's Daily Resource for Myasthenia Gravis News
If there’s one lesson the Army drilled into me that still applies today, it’s hurry up and wait. I thought I’d left that phrase behind, along with my combat boots […] The post In life with myasthenia gravis, it’s hurry up and wait appeared first on Myasthenia Gravis News.| Myasthenia Gravis News – The Web's Daily Resource for Myasthenia Gravis News
I do a lot of psychological and spiritual work on myself, and, because I do this work, I’ve come to believe that I am in tune with my body. Every […] The post I’m learning to accept I am a person living with myasthenia gravis appeared first on Myasthenia Gravis News.| Myasthenia Gravis News – The Web's Daily Resource for Myasthenia Gravis News
Rystiggo (rozanolixizumab-noli) can be safely self-administered by people with myasthenia gravis (MG), according to data from a Phase 3 clinical trial. Based on these findings, at-home administration of Rystiggo was […] The post At-home Rystiggo infusion safe; most MG patients prefer self-care appeared first on Myasthenia Gravis News.| Myasthenia Gravis News – The Web's Daily Resource for Myasthenia Gravis News
When I was 26 years old, my life as I knew it came to a screeching halt. It started one evening in March 2023, when I came home from a […] The post Guest Voice: A peek through the eyes of ocular myasthenia gravis appeared first on Myasthenia Gravis News.| Myasthenia Gravis News – The Web's Daily Resource for Myasthenia Gravis News
I vividly remember sitting in my third-grade classroom near the end of a school year. Sunshine always filled the classroom at the end of the year, particularly by 1 p.m., […] The post Finding dignity in the chronic illness waiting game appeared first on Myasthenia Gravis News.| Myasthenia Gravis News – The Web's Daily Resource for Myasthenia Gravis News
Anxiety related to COVID-19 is more prevalent among people with myasthenia gravis (MG) than among the general population, a study in Germany shows. For individuals with MG, the most pronounced […] The post Anxiety due to COVID-19 more prevalent in MG patients vs. public appeared first on Myasthenia Gravis News.| Myasthenia Gravis News – The Web's Daily Resource for Myasthenia Gravis News
Columnist Shawna Barnes was on the hunt for a clue to her MG symptoms when a late-night search on the internet brought her to huperzine A.| Myasthenia Gravis News
Columnist Mark Harrington, a retired history teacher, reflects on the life of Chief Opechancanough, who led the Powhatan Confederacy.| Myasthenia Gravis News
Circulating inflammatory molecules called cytokines may be associated with a risk for developing myasthenia gravis, a recent study suggests.| Myasthenia Gravis News
Columnist Sarah Bendiff has discovered her own techniques for surviving summer, when heat makes her flare-ups more likely.| Myasthenia Gravis News
Columnist Shawna Barnes delves into pyridostigmine bromide's history and its crucial role as an MG treatment.| Myasthenia Gravis News
Treatment decisions should be collaborative, says columnist Mark Harrington, who insists on being the final arbiter in his healthcare.| Myasthenia Gravis News
Columnist Allen Francis is learning from his brother with MG how best to process anger, and it begins with not suppressing it.| Myasthenia Gravis News
Columnist Shawna Barnes is ready for some emotional separation from myasthenia gravis, so she's delivering it a breakup letter.| Myasthenia Gravis News
Columnist Allen Francis says that his twin with MG finds chewing and swallowing more difficult as they both get older.| Myasthenia Gravis News
Columnist Mark Harrington says he mourns the loss of his identity and financial stability due to the fallout from myasthenia gravis.| Myasthenia Gravis News
Is myasthenia gravis actually a rare disease? Columnist Shawna Barnes addresses this common question in the MG community.| Myasthenia Gravis News
The FDA has approved once-daily zilucoplan as Zilbrysq for adults with generalized MG who are positive for antibodies targeting AChR.| Myasthenia Gravis News
Study data show long-term treatment with Zilbrysq led to sustained reductions in disease severity in generalized myasthenia gravis patients.| Myasthenia Gravis News
Columnist Shawna Barnes describes the different types of air hunger she experiences with MG, as well as their probable causes.| Myasthenia Gravis News
Exercise and physiotherapy can improve muscle strength, alleviate fatigue, and boost quality of life for people with myasthenia gravis.| Myasthenia Gravis News
Esteban holds a Master of Science in Immunology from the Instituto Politécnico Nacional in Mexico, focused on inflammation and metabolism. With five years of experience as a Medical Science Liaison, he has worked directly with physicians across a wide range of specialties, covering topics...| Myasthenia Gravis News
Treatment with nipocalimab in gMG patients led to significant reductions in disease severity, per top-line data from a pivotal Phase 3 trial.| Myasthenia Gravis News
Immunosuppressants, a class of medicines that broadly work to reduce immune system activity, are widely used to treat myasthenia gravis (MG).| Myasthenia Gravis News
More than half of MG patients in a study had fatigue and its severity correlated with disease worsening, crises, and delays in diagnosis.| Myasthenia Gravis News
Rituximab is an antibody-based therapy that may be used off-label in patients with certain types of myasthenia gravis.| Myasthenia Gravis News
A 64-year-old woman with dropped head syndrome was found to have a form of MG with antibodies against MuSK, and weak spine muscles.| Myasthenia Gravis News
Rituximab isn't officially approved for MG, but is used off-label when standard treatments fail, such as patients with anti-MuSK antibodies.| Myasthenia Gravis News
Columnist Shawna Barnes shares the hard-earned wisdom that would've helped her navigate life with myasthenia gravis after her diagnosis.| Myasthenia Gravis News
More than a quarter of gMG patients wait more than one year to receive an accurate diagnosis, according to study of five European countries.| Myasthenia Gravis News
Lindsey Shapiro is a science writer for Myasthenia Gravis News with a PhD in neuroscience. She covers the latest news and information on a variety of myasthenia gravis topics.| Myasthenia Gravis News
An open-label, multicenter Phase 2 clinical trial will test KYV-101 in people with refractory MG and positive for self-reactive antibodies.| Myasthenia Gravis News
Vyvgart is an approved infusion treatment for adults with generalized myasthenia gravis who are AChR-antibody positive.| Myasthenia Gravis News
Rystiggo is a myasthenia gravis treatment for adults with generalized MG. It's administered as an injection.| Myasthenia Gravis News
IImmunovant is prioritizing IMVT-1402 as its lead MG treatment candidate, with registrational clinical trials possible in the next year.| Myasthenia Gravis News
Batoclimab is an experimental antibody therapy being developed for generalized myasthenia gravis, along with other autoimmune disorders.| Myasthenia Gravis News
Columnist Shawna Barnes, who has seronegative myasthenia gravis, is happy with her treatments and sees no reason now to change them.| Myasthenia Gravis News
Getting a correct myasthenia gravis diagnosis may require a series of blood, nerve, muscle, and imaging tests.| Myasthenia Gravis News
Living with myasthenia gravis can be challenging, but the right strategies can help you manage your symptoms and ease their effects.| Myasthenia Gravis News
Fatigue linked to myasthenia gravis can affect a person’s quality of life, but there are coping strategies that can be used to minimize it.| Myasthenia Gravis News
Joana Carvalho is a managing science editor for BioNews with a PhD in biomedical sciences. She edits and fact-checks articles on a variety of rare and chronic disease topics.| Myasthenia Gravis News
Treatment with telitacicept for almost six months lessened disease activity in gMG adults positive for anti-AChR antibodies, per a study.| Myasthenia Gravis News
When symptoms of myasthenia gravis and a crisis left him so exhausted he wanted to give up, columnist Mark Harrington relied on his tenacity.| Myasthenia Gravis News
Marisa Wexler is a senior science writer for Myasthenia Gravis News with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of myasthenia gravis topics.| Myasthenia Gravis News
No description.| Myasthenia Gravis News
Soliris (eculizumab) is an infusion therapy approved for treating adults with generalized myasthenia gravis.| Myasthenia Gravis News
With a little knowledge and some planning, you can learn to not only live with myasthenia gravis but to thrive.| Myasthenia Gravis News
Bionews employs science writers and editors, most of whom have PhDs in the life sciences, as well as veteran journalists, to ensure news and information is well-written, accurate, and easy to understand.| Myasthenia Gravis News
Intravenous immunoglobulin (IVIG) is a compound that consists of immune globulins (immune proteins) that are usually administered into the bloodstream, to treat patients with severe or worsening myasthenia gravis.| Myasthenia Gravis News
Vanda Pinto is a science writer for Myasthenia Gravis News with a PhD in biomedicine. She covers the latest news and information on a variety of myasthenia gravis topics.| Myasthenia Gravis News
Steve Bryson is a science writer for Myasthenia Gravis News with a PhD in biochemistry. He covers the latest news and information on a variety of myasthenia gravis topics.| Myasthenia Gravis News
There are three main forms of myasthenia gravis, and while they differ, they all result in symptoms of muscle weakness and fatigue.| Myasthenia Gravis News
Muscle weakness and fatigue are hallmark symptoms of myasthenia gravis (MG), an autoimmune disorder. MG symptoms may come and go.| Myasthenia Gravis News
Myasthenia gravis occurs when self-reactive antibodies mistakenly attack the body's immune system, causing muscle weakness and fatigue.| Myasthenia Gravis News
Columnist Shawna Barnes shares three things she wishes she'd done differently in pursuit of a myasthenia gravis diagnosis.| Myasthenia Gravis News
Category archive page for Columns.| Myasthenia Gravis News
Margarida Maia is a science writer for Myasthenia Gravis News with a PhD in biomedical sciences. She covers the latest news and information on a variety of myasthenia gravis topics.| Myasthenia Gravis News
Thymectomy removes the thymus gland, aiming to cause remission from myasthenia gravis symptoms and a decrease in the need for medications.| Myasthenia Gravis News
There is no cure for myasthenia gravis, but different treatment approaches, such as medication and surgery, are available.| Myasthenia Gravis News
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto...| Myasthenia Gravis News
Generalized myasthenia gravis patients with mild muscle weakness saw more relief after surgery than those with moderate or severe weakness.| Myasthenia Gravis News
Plasmapheresis is a treatment for myasthenia gravis, commonly used during a myasthenic crisis and in preparation for thymectomy.| Myasthenia Gravis News
Mestinon (pyridostigmine bromide) is an oral therapy approved for the treatment of myasthenia gravis (MG).| Myasthenia Gravis News
Generalized myasthenia gravis is a chronic autoimmune neuromuscular condition that causes muscle weakness in different parts of the body.| Myasthenia Gravis News
Category archive page for News.| Myasthenia Gravis News
Remegen enrolled the first U.S. patient in a Phase 3 trial testing the safety and efficacy of telitacicept for generalized myasthenia gravis.| Myasthenia Gravis News
The anti-malaria drug dihydroartemisinin, known as DHA, showed promise for treating myasthenia gravis in a rat model of MG, per a new study.| Myasthenia Gravis News
Myasthenia gravis and summer heat are not friends, but these tactics have helped columnist Shawna Barnes reduce her heat intolerance.| Myasthenia Gravis News
Soliris effectively eased symptoms and reduced the need for other medications in adults with MG in a clinical practice setting, data show.| Myasthenia Gravis News
People with gMG with difficulty getting diagnosed or hard-to-manage disease symptoms accrue higher healthcare-related costs, per a study.| Myasthenia Gravis News
Having a thymectomy was found to significantly ease neurological symptoms in MG patients older than 65 with a thymus tumor, per a new study.| Myasthenia Gravis News
Scientists have identified a set of inflammatory molecules that could be useful as biomarkers to aid in MG diagnosis and classification.| Myasthenia Gravis News
Into-the-vein treatment with Vyvgart (efgartigimod alfa) resolved an MG crisis in a man who had failed to respond to prior treatments.| Myasthenia Gravis News
Myasthenia gravis is a neuromuscular disease characterized by weakness and fatigue that can affect muscles involved in voluntary movements.| Myasthenia Gravis News
